| Literature DB >> 25043814 |
Eloy D Hernandez1, Sang Jun Lee1, Ji Young Kim1, Angeles Duran1, Juan F Linares1, Tomoko Yajima1, Timo D Müller2, Matthias H Tschöp2, Steven R Smith3, Maria T Diaz-Meco1, Jorge Moscat4.
Abstract
The c-Jun NH(2)-terminal kinase (JNK) is a critical determinant of obesity-associated inflammation and glucose intolerance. The upstream mechanisms controlling this pathway are still unknown. Here we report that the levels of the PB1 domain-containing adaptor NBR1 correlated with the expression of proinflammatory molecules in adipose tissue from human patients with metabolic syndrome, suggesting that NBR1 plays a key role in adipose-tissue inflammation. We also show that NBR1 inactivation in the myeloid compartment impairs the function, M1 polarization, and chemotactic activity of macrophages; prevents inflammation of adipose tissue; and improves glucose tolerance in obese mice. Furthermore, we demonstrate that an interaction between the PB1 domains of NBR1 and the mitogen-activated kinase kinase 3 (MEKK3) enables the formation of a signaling complex required for the activation of JNK. Together, these discoveries identify an NBR1-MEKK3 complex as a key regulator of JNK signaling and adipose tissue inflammation in obesity.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25043814 PMCID: PMC4156534 DOI: 10.1016/j.cmet.2014.06.008
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287